126 related articles for article (PubMed ID: 7876548)
1. IL-7 in the cell-mediated immune response to a human pathogen.
Sieling PA; Sakimura L; Uyemura K; Yamamura M; Oliveros J; Nickoloff BJ; Rea TH; Modlin RL
J Immunol; 1995 Mar; 154(6):2775-83. PubMed ID: 7876548
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
3. IL-15, an immunomodulator of T cell responses in intracellular infection.
Jullien D; Sieling PA; Uyemura K; Mar ND; Rea TH; Modlin RL
J Immunol; 1997 Jan; 158(2):800-6. PubMed ID: 8992997
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy.
Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL
J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073
[TBL] [Abstract][Full Text] [Related]
5. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
6. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells.
Yogi Y; Endoh M; Banba T; Okamura H; Nomaguchi H
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):464-74. PubMed ID: 10347567
[TBL] [Abstract][Full Text] [Related]
8. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
[TBL] [Abstract][Full Text] [Related]
9. T cells bearing V beta 6 T cell receptors in the cell-mediated immune response to Mycobacterium leprae.
Wang X; Golkar L; Uyemura K; Ohmen JD; Villahermosa LG; Fajardo TT; Cellona RV; Walsh GP; Modlin RL
J Immunol; 1993 Dec; 151(12):7105-16. PubMed ID: 8258714
[TBL] [Abstract][Full Text] [Related]
10. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection.
García VE; Uyemura K; Sieling PA; Ochoa MT; Morita CT; Okamura H; Kurimoto M; Rea TH; Modlin RL
J Immunol; 1999 May; 162(10):6114-21. PubMed ID: 10229854
[TBL] [Abstract][Full Text] [Related]
11. IL-12 regulates T helper type 1 cytokine responses in human infectious disease.
Sieling PA; Wang XH; Gately MK; Oliveros JL; McHugh T; Barnes PF; Wolf SF; Golkar L; Yamamura M; Yogi Y; Uyemura K; Rea TH; Modlin RL
J Immunol; 1994 Oct; 153(8):3639-47. PubMed ID: 7930584
[TBL] [Abstract][Full Text] [Related]
12. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease.
de Jong R; Janson AA; Faber WR; Naafs B; Ottenhoff TH
J Immunol; 1997 Jul; 159(2):786-93. PubMed ID: 9218596
[TBL] [Abstract][Full Text] [Related]
13. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
15. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
16. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
18. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
Chattree V; Khanna N; Rao DN
Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
[TBL] [Abstract][Full Text] [Related]
19. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA
J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444
[TBL] [Abstract][Full Text] [Related]
20. The immunobiology of leprosy.
Kaplan G; Cohn ZA
Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
